Can-Fite BioPharma (CANF) Assets (2013 - 2026)
Can-Fite BioPharma (CANF) reported Assets of $8.06 million for Q2 2026, up 4.3% from $7.72 million a year earlier.
Analysis
Can-Fite BioPharma (CANF) Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Can-Fite BioPharma posted Assets of $9.51 million, up 4.3% from FY2024.
- Assets has a five-year compound annual growth rate of 0.0% (FY2020 to FY2025).
- By year, Assets came in at $9.12 million in FY2024 (-8.7%), $9.99 million in FY2023 (+7.6%), $9.28 million in FY2022 (-54.2%) and $20.25 million in FY2021 (+112.7%).
- Five-year quarterly Assets spans a low of $5.92 million in Q2 2024 and a high of $20.25 million in Q4 2021.
- Year over year, Assets gained in three of the last four quarters, with growth averaging 7.6%.
- The high point for year-over-year Assets in five years was Q4 2021 (growth of 112.7%); the low point was Q4 2022 (a decline of 54.2%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Can-Fite BioPharma | 1.82 Mn | -17.88 Mn | - | 8.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.06 Mn |
| Dec 31, 2025 | 9.51 Mn |
| Jun 30, 2025 | 7.72 Mn |
| Dec 31, 2024 | 9.12 Mn |
| Jun 30, 2024 | 5.92 Mn |
| Dec 31, 2023 | 9.99 Mn |
| Sep 30, 2023 | 9.17 Mn |
| Jun 30, 2023 | 11.03 Mn |
| Mar 31, 2023 | 13.49 Mn |
| Dec 31, 2022 | 9.28 Mn |
| Sep 30, 2022 | 12.71 Mn |
| Jun 30, 2022 | 14.75 Mn |
| Mar 31, 2022 | 17.85 Mn |
| Dec 31, 2021 | 20.25 Mn |
| Sep 30, 2021 | 14.64 Mn |
| Jun 30, 2021 | 9.68 Mn |
| Mar 31, 2021 | 12.74 Mn |
| Dec 31, 2020 | 9.52 Mn |
| Sep 30, 2020 | 13.33 Mn |
| Jun 30, 2020 | 12.80 Mn |
API Access
Can-Fite BioPharma Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=CANF&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "CANF", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=CANF&period=max&api_key=YOUR_API_KEY");
const data = await res.json();